St. Bernards Medical Center is changing the game in treating prostate cancer with their new non-invasive treatment.
For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...
King Charles III has been diagnosed with cancer and will be stepping back from ... There are various procedures to remove prostate tissue or widen the urethra. Some use the pulse of a laser beam, ...
The Division of Surgery aims to improve outcomes for patients undergoing ... and policy makers to create highly innovative solutions across seven broad themes. The Division of Cancer has a focus on ...
Kensington Palace reveals that the princess has had “planned abdominal surgery ... with cancer. The Palace clarifies that while undisclosed in its form, the monarch does not have prostate ...
If treatment is needed, the most common treatments are radiation therapy and surgery to remove the prostate gland. The operation usually eliminates an organ-confined cancer, but it can cause ...
Ontario's health minister says the province will now publicly fund a new treatment for advanced-stage prostate cancer. Health Canada approved Pluvicto in August 2022, but patients have been ...
LONDON — The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTO TM a new treatment for advanced-stage prostate ...
An Oregon cancer patient was “awake and conscious” when his face caught on fire during surgery — leaving him permanently disfigured, according to his family’s $900,000 lawsuit. John ...
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before ...